HOXB1 restored expression promotes apoptosis and differentiation in the HL60 leukemic cell line

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Petrini, Marina ^a   Felicetti, Federica ^a   Bottero, Lisabianca ^a   Errico, Maria C ^a   Morsilli, Ornella ^a   Boe, Alessandra ^a   De Feo, Alessandra ^a   Carè, Alessandra ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

AML; Apoptosis; Gene expression; HOXB1; Promoter methylation

Indexed keywords

CALCITRIOL; HOMEOBOX B1 PROTEIN; HOMEODOMAIN PROTEIN; RETINOIC ACID; RETROVIRUS VECTOR; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HL 60; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; GENETIC ANALYSIS; GENETIC TRANSDUCTION; HOX GENE; HOXB1 GENE; HUMAN; HUMAN CELL; MONOCYTIC LEUKEMIA; MYELOID LEUKEMIA; NUCLEOTIDE SEQUENCE; PROMOTER REGION; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE; UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

EID: 84886920190     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-101     Document Type: Article

References (48)

1. Garcia-Fernandez J. The genesis and evolution of homeobox gene clusters. Nat Rev Genet 2005, 6:881-892.
2. Scott MP. Vertebrate homeobox gene nomenclature. Cell 1992, 71:551-553. 10.1016/0092-8674(92)90588-4, 1358459.
3. Krumlauf R. Hox genes in vertebrate development. Cell 1994, 78:1991-2011.
4. Eklund EA. The role of hox proteins in leukemogenesis; insights into key regulatory events in hematopoiesis. Crit Rev Oncog 2011, 16:65-76. 10.1615/CritRevOncog.v16.i1-2.70, 3243967, 22150308.
5. Giampaolo A, Sterpetti P, Bulgarini D, Samoggia P, Pelosi E, Valtieri M, Peschle C. Key functional role and lineage-specific expression of selected HOXB genes in purified haematopoietic progenitor differentiation. Blood 1994, 84:3637-3647.
6. Sauvageau G, Lansdorp PM, Eaves CJ, Hogge DE, Dragowska WH, Reid DS, Largman C, Lawrence HJ, Hunphries RK. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc Natl Acad Sci USA 1994, 91:12223-12227. 10.1073/pnas.91.25.12223, 45409, 7527557.
7. Carè A, Testa U, Bassani A, Tritarelli E, Montesoro E, Samoggia P, Cianetti L, Peschle C. Coordinate expression and proliferative role of HOXB genes in activated adult T lymphocytes. Mol Cell Biol 1994, 14:4872-4877. 358859, 7911974.
8. Sauvageau G, Thorsteinsdottir U, Eaves CJ, Lawrence HJ, Largman C, Lansdorp PM, Humphries RK. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev 1995, 9:1753-1765. 10.1101/gad.9.14.1753, 7622039.
9. Giampaolo A, Felli N, Diverio D, Morsilli O, Samoggia P, Breccia M, Lo Coco F, Peschle C, Testa U. Expression pattern of HOXB6 homeobox gene in myelomonocytic differentiation and acute myeloid leukaemia. Leukaemia 2002, 16:1293-1301.
10. Gough SM, Slape CI, Aplan PD. NUP98 gene fusions and hematopoietic malignancies: common themes and new biological insights. Blood 2011, 118:6247-6257. 10.1182/blood-2011-07-328880, 3236115, 21948299.
11. Yan-Fang T, Dong W, Li P, Wen-Li Z, Jun L, Na W, Jian W, Xing F, Yan-Hong L, Jian N, Jian P. Analyzing the gene expression profile of pediatric acute myeloid leukemia with real-time PCR arrays. Cancer Cell Int 2012, 12:40-51. 10.1186/1475-2867-12-40, 3495223, 22958424.
12. Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J, Sukumar S. Compromised. HOXA5 function can limit p53 expression in human breast tumours. Nature 2000, 405:974-978. 10.1038/35016125, 10879542.
13. Chen H, Chung S, Sukumar S. HOXA5- induced apoptosis in breast cancer cells is mediated by caspase2 and 8. Mol Cell Biol 2004, 24:924-935. 10.1128/MCB.24.2.924-935.2004, 343791, 14701762.
14. Strathdee G, Sim A, Soutar R, Holyoake TL, Brown R. HOXA5 is targeted by cell - type specific CpG island methylation in normal cells and during the development of acute myeloid leukemia. Carcinogenesis 2007, 28:299-309.
15. Duong CV, Emes RD, Wessely F, Yacqub-Usman K, Clayton RN, Farrell WE. Quantitative, genome-wide analysis of the DNA methylome in sporadic pituitary adenomas. Endocr Relat Cancer 2012, 19:805-816. 10.1530/ERC-12-0251, 23045325.
16. Celetti A, Barba P, Cillo C, Rotoli B, Boncinelli E, Magli MC. Characteristic patterns of HOX gene expression in different types of human leukemia. Int J Cancer 1993, 53:237-244. 10.1002/ijc.2910530211, 7678830.
17. Oki Y, Issa JP. Epigenetic mechanisms in AML-a target for therapy. Cancer Treat Res 2010, 145:19-40.
18. Montesoro E, Castelli G, Morsilli O, Nisini R, Stafsnes MH, Carè A, Peschle C, Chelucci C. Unilineage monocytopoiesis in hematopoietic progenitor culture: switching cytokine treatment at all Mo developmental stages induces differentiation into dendritic cells. Cell Death Differ 2006, 13:250-259. 10.1038/sj.cdd.4401748, 16110321.
19. Felicetti F, Bottero L, Felli N, Mattia G, Labbaye C, Alvino E, Peschle C, Colombo MP, Carè A. Role of PLZF in melanoma progression. Oncogene 2004, 3:4567-4576.
20. Baird A, Coimbra R, Dang X, Lopez N, Lee J, Krzyzaniak M, Winfield R, Potenza B, Eliceiri BP. Cell surface localization and release of the candidate tumor suppressor Ecrg4 from polymorphonuclear cells and monocytes activate macrophages. J Leukoc Biol 2012, 91:773-781. 10.1189/jlb.1011503, 3336773, 22396620.
21. Pufahl L, Katryniok C, Schnur N, Sorg BL, Metzner J, Grez M, Steinhilber D. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3. J Cell Mol Med 2012, 16:1461-1473. 10.1111/j.1582-4934.2011.01420.x, 21883892.
22. Shah S, Sukumar N. The Hox genes and their roles in oncogenesis. Nat Rev Cancer 2010, 10:361-371. 10.1038/nrc2826, 20357775.
23. Asatiani E, Huang WX, Wang A, Rodriguez Ortner E, Cavalli LR, Haddad BR, Gelmann EP. Deletion, methylation, and expression of the NKX3.1. Cancer Res 2005, 65:1164-1173. 10.1158/0008-5472.CAN-04-2688, 15734999.
24. Carrio M, Arderiu G, Myers C, Boudreau NJ. Homeobox D10 induces phenotypic reversion of breast tumor cells in a three-dimensional culture model. Cancer Res 2005, 65:7177-7185. 10.1158/0008-5472.CAN-04-1717, 16103068.
25. Wang L, Chen S, Xue M, Zhong J, Wang X, Gan L, Lam EK, Liu X, Zhang J, Zhou T, Yu J, Jin H, Si J. Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis. Mol Med 2012, 18:389-400. 3356424, 22160393.
26. Strathdee G, Holyoake TL, Sim A, Parker A, Oscier DG, Melo JV, Meyer S, Eden T, Dickinson AM, Mountford JC, Jorgensen HG, Soutar R, Brown R. Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis. Clin Cancer Res 2007, 13:5048-5055. 10.1158/1078-0432.CCR-07-0919, 17785556.
27. Lassus P, Araya XO, Lazebnik Y. Requirement for caspase 2 in stress induced apoptosis before mitochondrial permeabilization. Science 2002, 297:1352-1354. 10.1126/science.1074721, 12193789.
28. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 2000, 288:870-874. 10.1126/science.288.5467.870, 10797012.
29. Busch CR, Heat DD, Hubberstey A. Sensitive genetic biomarkers for determining apoptosis in the brown bullhead (Ameiurus nebulosus). Gene 2004, 329:1-10.
30. Yang M, Cao X, Yu MC, Gu JF, Shen ZH, Ding M, de Yu B, Zheng S, Liu X. Potent antitumor efficacy of ST13 for colorectal cancer mediated by oncolytic adenovirus via mitochondrial apoptotic cell death. Hum Gene Ther 2008, 19:343-353. 10.1089/hum.2007.0137, 18355116.
31. Bhoopathi P, Chetty C, Gujrati M, Dinh DH, Rao JS, Lakka S. Cathepsin B facilitates autophagy-mediated apoptosis in SPARC overexpressed primitive neuroectodermal tumor cells. Cell Death Differ 2010, 17:1529-1539. 10.1038/cdd.2010.28, 3025815, 20339379.
32. Di Martino JF, Lacayo NJ, Varadi M, Li L, Saraiya C, Ravindranath Y, Yu R, Sikic BI, Raimondi SC, Dahl GV. Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein. Leukemia 2006, 20:426-432. 10.1038/sj.leu.2404102, 16424866.
33. Franklin EE, Robertson J. Requirement of Apaf-1 for mitochondrial events and the cleavage or activation of all procaspases during genotoxic stress-induced apoptosis. Biochem J 2007, 405:115-122. 1925245, 17348858.
34. Germain M, Milburn J, Duronio V. MCL-1 inhibits BAX in the absence of MCL-1/BAX Interaction. J Biol Chem 2008, 283:6384-6392. 10.1074/jbc.M707762200, 18089567.
35. Yu H, Zou Y, Jiang L, Yin Q, He X, Chen L, Zhang Z, Gu W, Li Y. Induction of apoptosis in non-small cell lung cancer by downregulation of MDM2 using pH-responsive PMPC-b-PDPA/siRNA complex nanoparticles. Biomaterials 2013, 34:2738-2747. 10.1016/j.biomaterials.2012.12.042, 23352573.
36. Qin JJ, Nag S, Voruganti S, Wang W, Zhang R. Natural product MDM2 inhibitors: anticancer activity and mechanisms of action. Curr Med Chem 2012, 19:5705-5725. 10.2174/092986712803988910, 22830335.
37. Jung SY, Jeon HK, Choi JS, Kim YJ. Reduced expression of FASN through SREBP-1 down-regulation is responsible for hypoxic cell death in HepG2 cells. J Cell Biochem 2012, 113:3730-3739. 10.1002/jcb.24247, 22786746.
38. Turrado C, Puig T, García-Cárceles J, Artola M, Benhamú B, Ortega-Gutiérrez S, Relat J, Oliveras G, Blancafort A, Haro D, Marrero PF, Colomer R, López-Rodríguez ML. New synthetic inhibitors of fatty acid synthase with anticancer activity. J Med Chem 2012, 55:5013-5023. 10.1021/jm2016045, 22559865.
39. Hole PS, Darley RL, Tonks A. Do reactive oxygen species play a role in myeloid leukemias?. Blood 2011, 117:5816-5826. 10.1182/blood-2011-01-326025, 21398578.
40. Chen KS, Hsiao YC, Kuo DY, Chou MC, Chu SC, Hsieh YS, Lin TH. Tannic acid-induced apoptosis and enhanced sensitivity to arsenic trioxide in human leukemia HL-60 cells. Leuk Res 2009, 33:297-307. 10.1016/j.leukres.2008.08.006, 18790533.
41. Cai Y, Qiu S, Gao X, Gu SZ, Liu ZJ. iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes. Apoptosis 2012, 17:777-783. 10.1007/s10495-012-0728-z, 22538442.
42. Ferretti E, Li B, Zewdu R, Wells V, Hebert JM, Karner C, Anderson MJ, Williams T, Dixon J, Dixon MJ, Depew MJ, Selleri L. A conserved Pbx-Wnt-p63-Irf6 regulatory module controls face morphogenesis by promoting epithelial apoptosis. Dev Cell 2011, 21:627-641. 10.1016/j.devcel.2011.08.005, 3199312, 21982646.
43. Adamson ED, Mercola D. Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival. Tumour Biol 2002, 23:93-102. 10.1159/000059711, 12065847.
44. Zheng L, Pu J, Jiang G, Weng M, He J, Mei H, Hou X, Tong Q. Abnormal expression of early growth response 1 in gastric cancer: association with tumor invasion, metastasis and heparanase transcription. Pathol Int 2010, 60:268-277. 10.1111/j.1440-1827.2010.02512.x, 20403028.
45. Staber PB, Linkesch W, Zauner D, Beham-Schmid C, Guelly C, Schauer S, Sill H, Hoefler G. Common alterations in gene expression and increased proliferation in recurrent acute myeloid leukemia. Oncogene 2004, 23:894-904. 10.1038/sj.onc.1207192, 14749762.
46. Ogura T, Evans RM. Evidence for two distinct retinoic acid response pathways for HOXB1 gene regulation. Proc Natl Acad Sci USA 1995, 17:392-396.
47. Karpf AR, Jones DA. Reactivating the expression of methylation silenced genes in human cancer. Oncogene 2002, 21:5496-5503. 10.1038/sj.onc.1205602, 12154410.
48. Claus R, Almstedt M, Lübbert M. Epigenetic treatment of hematopoietic malignancies: in vivo targets of demethylating agents. Semin Oncol 2005, 32:511-520. 10.1053/j.seminoncol.2005.07.024, 16210092.